CYP2D6 Genotype on the Clinical Effect of Tamoxifen
Status:
Unknown status
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the impact of CYP2D6 Genotype on the clinical
effects of tamoxifen using with samples from prospective randomized multicenter
study(ASTRRA).
Details
Lead Sponsor:
Korea University Anam Hospital
Collaborators:
Korean Breast Cancer Study Group National Cancer Center, Korea